3D Bioprinting Market Share

Market Share of 3D Bioprinting Industry

The 3D bioprinting market is very competitive in nature. The market is concentrated due to the presence of various small and large players. Some of the significant players in the market are 3D Systems Corporation, Aspect Biosystems Ltd, GeSIM GmbH, Cellink AB, Cyfuse Biomedical KK, and Envision TEC GmbH.

• September 2022 - The Indian Institute of Science (IISc) announced its collaboration with CELLINK, a Sweden-based bioprinting solutions company, to provide two to three bioprinters to the Centre of Excellence (CoE), each of which uses a different printing technology at its own cost. India is expected to have its first dedicated center for 3D bioprinting technology in about two months at the Indian Institute of Science (IISc). IISc plans to set up its CoE in 3D bioprinting at its Centre for Biosystems Science and Engineering (BSSE). The CoE aims to advance the field by becoming a resource center for researchers, biopharma companies, hospitals, etc.
• June 2022 - REGEMAT 3D, a company at the forefront of personalized bio fabrication solutions, announced a partnership with Humabiologics, a company providing human-derived biomaterials for regenerative medicine, in response to the growing demand and to serve a broader life sciences customer base of the industry partners and academic institutions in the European bioprinting and drug testing market.

3D Bioprinting Market Leaders

1. Cellink

2. 3D Systems Corporation

3. 3D Bioprinting Solutions

4. REGEMAT 3D

5. Aspect Biosystems Ltd

*Disclaimer: Major Players sorted in no particular order